Literature DB >> 34657160

Cognitive behavioral therapy for insomnia has sustained effects on insomnia, fatigue, and function among people with chronic heart failure and insomnia: the HeartSleep Study.

Nancy S Redeker1, Henry Klar Yaggi2, Daniel Jacoby2, Christopher S Hollenbeak3, Stephen Breazeale1, Samantha Conley1, Youri Hwang1, Joanne Iennaco1, Sarah Linsky1, Uzoji Nwanaji-Enwerem1, Meghan O'Connell1, Sangchoon Jeon1.   

Abstract

STUDY
OBJECTIVES: Insomnia is common among adults with chronic heart failure (HF) and associated with daytime symptoms and decrements in function. The purpose of this randomized controlled trial (RCT) was to evaluate the sustained effects over one year of CBT-I (Healthy Sleep: HS) compared with HF self-management education (Healthy Hearts; attention control: HH) on insomnia severity, sleep characteristics, symptoms, and function among people with stable HF. The primary outcomes were insomnia severity, actigraph-recorded sleep efficiency, and fatigue.
METHODS: We randomized adults with stable HF with preserved or reduced ejection fraction who had at least mild insomnia (Insomnia severity index >7) in groups to HS or HH (4 sessions/8 weeks). We obtained wrist actigraphy and measured insomnia severity, self-reported sleep characteristics, symptoms (fatigue, excessive daytime sleepiness, anxiety, depression), and six-minute walk distance at baseline, within one month of treatment, and at 6 and 12 months. We used general linear mixed models (GLMM) and generalized estimating equations (GEE) to evaluate the effects.
RESULTS: The sample included 175 participants (M age = 63 ± 12.9 years; 43% women; 18% Black; 68% New York Heart Association Class II or II; 33%; LVEF < 45%) randomized to HS (n = 91) or HH (n = 84). HS had sustained effects on insomnia severity, sleep quality, self-reported sleep latency and efficiency, fatigue, excessive daytime sleepiness, and six-minute walk distance at 12 months.
CONCLUSIONS: CBT-I produced sustained improvements in insomnia, fatigue, daytime sleepiness, and objectively measured physical function among adults with chronic HF, compared with a robust HF self-management program that included sleep hygiene education. CLINICAL TRIAL INFORMATION: Insomnia Self-Management in Heart Failure; https://clinicaltrials.gov/ct2/show/NCT02660385; NCT02660385. © Sleep Research Society 2021. Published by Oxford University Press on behalf of the Sleep Research Society. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  actigraphy; cognitive behavioral therapy; fatigue; function; heart failure; insomnia; self-management; sleep

Mesh:

Year:  2022        PMID: 34657160      PMCID: PMC8754495          DOI: 10.1093/sleep/zsab252

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   6.313


  62 in total

1.  Feasibility and Efficacy of a Self-Management Intervention for Insomnia in Stable Heart Failure.

Authors:  Nancy S Redeker; Sangchoon Jeon; Laura Andrews; John Cline; Daniel Jacoby; Vahid Mohsenin
Journal:  J Clin Sleep Med       Date:  2015-10-15       Impact factor: 4.062

2.  Global Public Health Burden of Heart Failure.

Authors:  Gianluigi Savarese; Lars H Lund
Journal:  Card Fail Rev       Date:  2017-04

3.  Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis.

Authors:  Jade Q Wu; Erica R Appleman; Robert D Salazar; Jason C Ong
Journal:  JAMA Intern Med       Date:  2015-09       Impact factor: 21.873

4.  Efficacy of brief behavioral treatment for chronic insomnia in older adults.

Authors:  Daniel J Buysse; Anne Germain; Douglas E Moul; Peter L Franzen; Laurie K Brar; Mary E Fletcher; Amy Begley; Patricia R Houck; Sati Mazumdar; Charles F Reynolds; Timothy H Monk
Journal:  Arch Intern Med       Date:  2011-01-24

5.  Effects of Cognitive Behavioral Therapy for Insomnia on Sleep-Related Cognitions Among Patients With Stable Heart Failure.

Authors:  Nancy S Redeker; Sangchoon Jeon; Laura Andrews; John Cline; Vahid Mohsenin; Daniel Jacoby
Journal:  Behav Sleep Med       Date:  2017-08-22       Impact factor: 2.964

6.  The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure.

Authors:  G H Guyatt; M J Sullivan; P J Thompson; E L Fallen; S O Pugsley; D W Taylor; L B Berman
Journal:  Can Med Assoc J       Date:  1985-04-15       Impact factor: 8.262

7.  A randomized controlled trial of CBT-I and PAP for obstructive sleep apnea and comorbid insomnia: main outcomes from the MATRICS study.

Authors:  Jason C Ong; Megan R Crawford; Spencer C Dawson; Louis F Fogg; Arlener D Turner; James K Wyatt; Maria I Crisostomo; Bantu S Chhangani; Clete A Kushida; Jack D Edinger; Sabra M Abbott; Roneil G Malkani; Hrayr P Attarian; Phyllis C Zee
Journal:  Sleep       Date:  2020-09-14       Impact factor: 5.849

8.  Does comorbid obstructive sleep apnea impair the effectiveness of cognitive and behavioral therapy for insomnia?

Authors:  Alexander Sweetman; Leon Lack; Sky Lambert; Michael Gradisar; Jodie Harris
Journal:  Sleep Med       Date:  2017-09-22       Impact factor: 3.492

9.  The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research.

Authors:  D J Buysse; C F Reynolds; T H Monk; S R Berman; D J Kupfer
Journal:  Psychiatry Res       Date:  1989-05       Impact factor: 3.222

10.  Six-minute walk test: prognostic value and effects of nebivolol versus placebo in elderly patients with heart failure from the SENIORS trial.

Authors:  Marcelo C Shibata; Jordan Curl-Roper; Dirk J Van Veldhuisen; Michael Roughton; Andrew J S Coats; Marcus Flather
Journal:  Clin Res Cardiol       Date:  2020-11-02       Impact factor: 5.460

View more
  1 in total

1.  Symptom Cluster Profiles Among Adults with Insomnia and Heart Failure.

Authors:  Samantha Conley; Sangchoon Jeon; Stephen Breazeale; Meghan O'Connell; Christopher S Hollenbeak; Daniel Jacoby; Sarah Linsky; Henry Klar Yaggi; Nancy S Redeker
Journal:  Behav Sleep Med       Date:  2022-04-07       Impact factor: 3.492

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.